Blood brain barrier (BBB) disruption by tumor treating fields (TTFields) in a human 3D in vitro model

被引：0
|
作者：
Salvador, Ellaine [1 ]
Kessler, Almuth F. [1 ]
Koeppl, Theresa [1 ]
Schoenhaerl, Sebastian [1 ]
Burek, Malgorzata [1 ]
Brami, Catherine Tempel [2 ]
Voloshin, Tali [2 ]
Giladi, Moshe [2 ]
Ernestus, Ralf-Ingo [1 ]
Loehr, Mario [1 ]
Foerster, Carola Y. [1 ]
Hagemann, Carsten [1 ]
机构：
[1] Univ Hosp Wurzburg, Wurzburg, Germany
[2] Novocure Ltd, Haifa, Israel
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
387
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Reversible blood-brain barrier (BBB) disruption by Tumor Treating Fields (TTFields) in a human 3Din vitro model
    Salvador, E.
    Kessler, A. F.
    Koeppl, T.
    Schoenhaerl, S.
    Burek, M.
    Brami, C. Tempel
    Voloshin, T.
    Giladi, M.
    Ernestus, R.
    Loehr, M.
    Foerster, C.
    Hagemann, C.
    NEURO-ONCOLOGY, 2022, 24
  • [2] TUMOR TREATING FIELDS (TTFIELDS) AT A FREQUENCY OF 100 KHZ AND 170 KHZ OPEN THE BLOOD-BRAIN BARRIER (BBB) IN A 3D IN VITRO BBB-MODEL
    Lysinger, A. S.
    Salvador, E.
    Vormwald, L.
    Ernestus, R.
    Loehr, M.
    Hagemann, C.
    NEURO-ONCOLOGY, 2024, 26
  • [3] The blood brain barrier (BBB) permeability is altered by Tumor Treating Fields (TTFields) in vitro and in vivo
    Kessler, A. F.
    Salvador, E.
    Schaeffer, C.
    Burek, M.
    Ruschig, U.
    Tempel-Brami, C.
    Sela, Voloshin T.
    Giladi, M.
    Ernestus, R. -, I
    Loehr, M.
    Foerster, C.
    Hagemann, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S60 - S60
  • [4] Tumor treating fields (TTFields) affect blood brain barrier (BBB) integrity in vitro and in vivo
    Kessler, Almuth F.
    Schaeffer, Clara M.
    Burek, Malgorzata
    Ruschig, Ursula
    Tempel-Brami, Catherine
    Voloshin, Tali
    Giladi, Moshe
    Salvador, Ellaine
    Ernestus, Ralf-Ingo
    Loehr, Mario
    Foerster, Carole
    Hagemann, Carsten
    CANCER RESEARCH, 2019, 79 (13)
  • [5] Blood Brain Barrier (BBB) Integrity Is Affected By Tumor Treating Fields (TTFields) in Vitro and In Vivo
    Kessler, A. F.
    Salvador, E.
    Domroese, D.
    Burek, M.
    Schaeffer, C.
    Brami, C. Tempel
    Voloshin, T.
    Giladi, M.
    Ernestus, R. I.
    Loehr, M.
    Foerster, C.
    Hagemann, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S162 - S163
  • [6] EFFECTS OF TUMOR TREATING FIELDS (TTFIELDS) ON BLOOD BRAIN BARRIER (BBB) PERMEABILITY
    Kessler, Almuth
    Schaeffer, Clara
    Burek, Malgorzata
    Ruschig, Ursula
    Brami, Catherine Tempel
    Voloshin, Tali
    Giladi, Moshe
    Ernestus, Rolf-Ingo
    Loehr, Mario
    Foerster, Carola
    Hagemann, Carsten
    NEURO-ONCOLOGY, 2018, 20 : 93 - 94
  • [7] EFFECTS OF TUMOR TREATING FIELDS (TTFIELDS) ON BLOOD BRAIN BARRIER (BBB) PERMEABILITY
    Kessler, A. F.
    Schaeffer, C.
    Burek, M.
    Ruschig, U.
    Ernestus, R.
    Loehr, M.
    Foerster, C.
    Hagemann, C.
    NEURO-ONCOLOGY, 2018, 20 : 286 - 286
  • [8] Tumor Treating Fields (TTFields) Induce Cell Junction Alterations in a Human 3D In Vitro Model of the Blood-Brain Barrier
    Salvador, Ellaine
    Koeppl, Theresa
    Hoermann, Julia
    Schoenhaerl, Sebastian
    Bugaeva, Polina
    Kessler, Almuth F.
    Burek, Malgorzata
    Ernestus, Ralf-Ingo
    Loehr, Mario
    Hagemann, Carsten
    PHARMACEUTICS, 2023, 15 (01)
  • [9] ALTERATION OF BLOOD BRAIN BARRIER (BBB) PERMEABILITY BY TUMOR TREATING FIELDS (TTFIELDS) IN VIVO
    Kessler, A. F.
    Salvador, E.
    Domroese, D.
    Burek, M.
    Brami, C. Tempel
    Sela, T. Voloshin
    Giladi, M.
    Ernestus, R.
    Loehr, M.
    Foerster, C.
    Hagemann, C.
    NEURO-ONCOLOGY, 2019, 21 : 49 - 49
  • [10] THE BLOOD BRAIN BARRIER (BBB) PERMEABILITY IS ALTERED BY TUMOR TREATING FIELDS (TTFIELDS) IN VIVO
    Schulz, Ellina
    Kessler, Almuth F.
    Salvador, Ellaine
    Domrose, Dominik
    Burek, Malgorzata
    Brami, Catherine Tempel
    Sela, Tali Voloshin
    Giladi, Moshe
    Ernestus, Ralf-Ingo
    Lohr, Mario
    Forster, Carola
    Hagemann, Carsten
    NEURO-ONCOLOGY, 2019, 21 : 82 - 82
12345